ResearcherFirst Hospital of Jilin UniversityActive in the last 2 years

Di Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7992-1771; OpenAlex author ID A5046136240. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Efficacy and Safty analysis of low-energy X ray IORT in the treatment of resectable pancreatic cancer Co-author DOI 10.21203/rs.3.rs-3951098/v1 ↗
Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins. Co-author DOI 10.3892/ijo.2018.4315 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chunbo Zhao · 1 shared paper, 2024 · strength 0.26
- Paper Efficacy and Safty analysis of low-energy X ray IORT in the treatment of resectable pancreatic cancer DOI 10.21203/rs.3.rs-3951098/v1 ↗
Qian Zhang · 1 shared paper, 2024 · strength 0.26
- Paper Efficacy and Safty analysis of low-energy X ray IORT in the treatment of resectable pancreatic cancer DOI 10.21203/rs.3.rs-3951098/v1 ↗
Miao Yu · 1 shared paper, 2018 · strength 0.10
- Paper Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-a… DOI 10.3892/ijo.2018.4315 ↗
Ping Zhang · 1 shared paper, 2018 · strength 0.10
- Paper Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-a… DOI 10.3892/ijo.2018.4315 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.